Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 27,649Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14RIGEL PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 11497743

Drug Substance Claim :

Drug Product Claim :

Application Number : 215814

Patent Use Code : U-3495

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

02

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 11376246

Drug Substance Claim :

Drug Product Claim :

Application Number : 215814

Patent Use Code : U-3495

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

03

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 11013734

Drug Substance Claim :

Drug Product Claim :

Application Number : 215814

Patent Use Code : U-3495

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

04

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 11013733

Drug Substance Claim :

Drug Product Claim :

Application Number : 215814

Patent Use Code : U-3496

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

05

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 9834539

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215814

Patent Use Code : U-3497

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-18

blank

06

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 11738018

Drug Substance Claim :

Drug Product Claim :

Application Number : 215814

Patent Use Code : U-3684

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-17

blank

07

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 12275715

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215814

Patent Use Code : U-3684

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-18

blank

08

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 10532047

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 215814

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

09

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 12053463

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215814

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank

10

arrow
FCE Pharma
Not Confirmed
arrow
FCE Pharma
Not Confirmed

OLUTASIDENIB

US Patent Number : 10959994

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215814

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-16

blank